My Fulbright aims to build a future where children with cerebral palsy can access safe and effective cell therapies. Together with Duke University, we have designed a program that supports the approval of umbilical cord blood treatment for cerebral palsy via rigorous research, training, advocacy and implementation.
Madison is a Senior Research Fellow specialising in cell therapies at the Cerebral Palsy Alliance Research Institute. Her research is dedicated to those living with disability and aims to progress clinical trials and access to safe and effective treatments.
As a Fulbright Scholar, Madison will collaborate with experts at Duke University to explore how umbilical cord blood is being investigated as a treatment for cerebral palsy. Cerebral palsy remains the most common physical disability in childhood, with limited treatment options. Madison’s vision is to help deliver the world’s first approved cell therapy through a deep and enduring US-Australian partnership.